-
1
-
-
33947192117
-
Drug-eluting stents - a note of caution
-
Harper RW. Drug-eluting stents - a note of caution. Med J Aust 2007; 186: 253-255.
-
(2007)
Med J Aust
, vol.186
, pp. 253-255
-
-
Harper, R.W.1
-
2
-
-
0141613164
-
Primary angioplasty versus intravenous thrombolysis for acute myocardial infarction
-
CD001560
-
Cucherat M, Bonnefoy E, Tremeau G. Primary angioplasty versus intravenous thrombolysis for acute myocardial infarction. Cochrane Database Syst Rev 2003; (3): CD001560.
-
(2003)
Cochrane Database Syst Rev
, Issue.3
-
-
Cucherat, M.1
Bonnefoy, E.2
Tremeau, G.3
-
3
-
-
0033606918
-
SHOCK Investigators. Early revascularization in acute myocardial infarction complicated by cardiogenic shock
-
Hochman JS, Sleeper LA, Webb JG, et al; SHOCK Investigators. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 1999; 341: 625-634.
-
(1999)
N Engl J Med
, vol.341
, pp. 625-634
-
-
Hochman, J.S.1
Sleeper, L.A.2
Webb, J.G.3
-
4
-
-
29544444716
-
REACT Trial Investigators. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction
-
Gershlick AH, Stephens-Lloyd A, Hughes S, et al; REACT Trial Investigators. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. N Engl J Med 2005; 353: 2758-2768.
-
(2005)
N Engl J Med
, vol.353
, pp. 2758-2768
-
-
Gershlick, A.H.1
Stephens-Lloyd, A.2
Hughes, S.3
-
5
-
-
34848833529
-
Assessing the influence of primary angioplasty compared with thrombolysis and its relationship to time delay: A Bayesian evidence synthesis
-
Asseburg C, Bravo Vergel Y, Palmer S, et al. Assessing the influence of primary angioplasty compared with thrombolysis and its relationship to time delay: a Bayesian evidence synthesis. Heart 2007; 93: 1244-1250.
-
(2007)
Heart
, vol.93
, pp. 1244-1250
-
-
Asseburg, C.1
Bravo Vergel, Y.2
Palmer, S.3
-
6
-
-
33845453212
-
Occluded Artery Trial Investigators. Coronary intervention for persistent occlusion after myocardial infarction
-
Hochman JS, Lamas GA, Buller CE, et al; Occluded Artery Trial Investigators. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med 2006; 355: 2395-2407.
-
(2006)
N Engl J Med
, vol.355
, pp. 2395-2407
-
-
Hochman, J.S.1
Lamas, G.A.2
Buller, C.E.3
-
7
-
-
33750095914
-
Early invasive versus conservative strategies for unstable angina & non-ST-elevation myocardial infarction in the stent era
-
CD004815
-
Hoenig MR, Doust JA, Aroney CN, Scott IA. Early invasive versus conservative strategies for unstable angina & non-ST-elevation myocardial infarction in the stent era. Cochrane Database Syst Rev 2006; (3): CD004815.
-
(2006)
Cochrane Database Syst Rev
, Issue.3
-
-
Hoenig, M.R.1
Doust, J.A.2
Aroney, C.N.3
Scott, I.A.4
-
8
-
-
20444504004
-
Percutaneous coronary interventions vs conservative therapy in nonacute coronary disease. A meta-analysis
-
Katritsis DG, Ioannidis JP. Percutaneous coronary interventions vs conservative therapy in nonacute coronary disease. A meta-analysis. Circulation 2005; 111: 2906-2912.
-
(2005)
Circulation
, vol.111
, pp. 2906-2912
-
-
Katritsis, D.G.1
Ioannidis, J.P.2
-
9
-
-
34247113737
-
COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease
-
Boden WE, O'Rourke RA, Teo KK, et al; COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356: 1503-1516.
-
(2007)
N Engl J Med
, vol.356
, pp. 1503-1516
-
-
Boden, W.E.1
O'Rourke, R.A.2
Teo, K.K.3
-
10
-
-
38449101262
-
Systematic review: The comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery
-
Bravata DM, Gienger AL, McDonald KM, et al. Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. Ann Intern Med 2007; 147: 703-716.
-
(2007)
Ann Intern Med
, vol.147
, pp. 703-716
-
-
Bravata, D.M.1
Gienger, A.L.2
McDonald, K.M.3
-
11
-
-
33947606182
-
Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II). A randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease
-
Hueb W, Lopes NH, Gersh BJ, et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II). A randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 2007; 115: 1082-1089.
-
(2007)
Circulation
, vol.115
, pp. 1082-1089
-
-
Hueb, W.1
Lopes, N.H.2
Gersh, B.J.3
-
12
-
-
34147176083
-
Stent thrombosis late after implantation of first-generation drug-eluting stents. A cause for concern
-
Camenzind E, Steg PG, Wijns W. Stent thrombosis late after implantation of first-generation drug-eluting stents. A cause for concern. Circulation 2007; 115: 1440-1455.
-
(2007)
Circulation
, vol.115
, pp. 1440-1455
-
-
Camenzind, E.1
Steg, P.G.2
Wijns, W.3
-
13
-
-
4143096183
-
A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents
-
Babapulle MN, Joseph L, Bélisle P, et al. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet 2004; 364: 583-591.
-
(2004)
Lancet
, vol.364
, pp. 583-591
-
-
Babapulle, M.N.1
Joseph, L.2
Bélisle, P.3
-
14
-
-
17844373254
-
Incidence, predictors, and outcome of thrombosis after successful implementation of drug-eluting stents
-
Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implementation of drug-eluting stents. JAMA 2005; 293: 2126-2130.
-
(2005)
JAMA
, vol.293
, pp. 2126-2130
-
-
Iakovou, I.1
Schmidt, T.2
Bonizzoni, E.3
-
15
-
-
33845319222
-
BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: An observational study of drug-eluting versus bare-metal stents
-
Pfisterer M, Brunner-La Rocca HP, Buser PT, et al; BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006; 48: 2584-2591.
-
(2006)
J Am Coll Cardiol
, vol.48
, pp. 2584-2591
-
-
Pfisterer, M.1
Brunner-La Rocca, H.P.2
Buser, P.T.3
-
16
-
-
33847705701
-
Stent thrombosis in randomized clinical trials of drug-eluting stents
-
Mauri L, Hsieh WH, Massaro JM, et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007; 356: 1020-1029.
-
(2007)
N Engl J Med
, vol.356
, pp. 1020-1029
-
-
Mauri, L.1
Hsieh, W.H.2
Massaro, J.M.3
-
17
-
-
34548542073
-
Outcomes associated with drug-eluting bare-metal stents: A collaborative network meta-analysis
-
Stettler C, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting bare-metal stents: a collaborative network meta-analysis. Lancet 2007; 370: 937-948.
-
(2007)
Lancet
, vol.370
, pp. 937-948
-
-
Stettler, C.1
Wandel, S.2
Allemann, S.3
-
18
-
-
33846125284
-
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation
-
Eisenstein EL, Anstrom KJ, Kong DF, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 2007; 297: 159-168.
-
(2007)
JAMA
, vol.297
, pp. 159-168
-
-
Eisenstein, E.L.1
Anstrom, K.J.2
Kong, D.F.3
-
19
-
-
33745960402
-
Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: Results from the PREMIER registry
-
Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 2006; 113: 2803-2809.
-
(2006)
Circulation
, vol.113
, pp. 2803-2809
-
-
Spertus, J.A.1
Kettelkamp, R.2
Vance, C.3
-
20
-
-
33745303804
-
Narrative review: Drug-eluting stents for the management of restenosis: a critical appraisal of the evidence
-
Tung R, Kaul S, Diamond GA, Shah PK. Narrative review: drug-eluting stents for the management of restenosis: a critical appraisal of the evidence. Ann Intern Med 2006; 144: 913-919.
-
(2006)
Ann Intern Med
, vol.144
, pp. 913-919
-
-
Tung, R.1
Kaul, S.2
Diamond, G.A.3
Shah, P.K.4
-
21
-
-
0037120818
-
TACTICS-TIMI 18 Investigators. Treat Angina with aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy - Thrombolysis In Myocardial Infarction. Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction
-
Mahoney EM, Jurkovitz CT, Chu H, et al; TACTICS-TIMI 18 Investigators. Treat Angina with aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy - Thrombolysis In Myocardial Infarction. Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction. JAMA 2002; 288: 1851-1858.
-
(2002)
JAMA
, vol.288
, pp. 1851-1858
-
-
Mahoney, E.M.1
Jurkovitz, C.T.2
Chu, H.3
-
22
-
-
33947718150
-
Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: Prospective observational study
-
Griffin SC, Barber JA, Manca A, et al. Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational study. BMJ 2007; 334: 624-631.
-
(2007)
BMJ
, vol.334
, pp. 624-631
-
-
Griffin, S.C.1
Barber, J.A.2
Manca, A.3
-
23
-
-
27944441327
-
A systematic review and economic analysis of drug-eluting coronary stents available in Australia
-
Lord SJ, Howard K, Allen F, et al. A systematic review and economic analysis of drug-eluting coronary stents available in Australia. Med J Aust 2005; 183: 464-471.
-
(2005)
Med J Aust
, vol.183
, pp. 464-471
-
-
Lord, S.J.1
Howard, K.2
Allen, F.3
-
24
-
-
3543064732
-
Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: Results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients with De Novo Native Coronary Artery Lesions (SIRIUS) trial
-
Cohen DJ, Bakhai A, Shi C, et al. Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients with De Novo Native Coronary Artery Lesions (SIRIUS) trial. Circulation 2004; 110: 508-514.
-
(2004)
Circulation
, vol.110
, pp. 508-514
-
-
Cohen, D.J.1
Bakhai, A.2
Shi, C.3
-
25
-
-
24644523719
-
Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: Randomised Basal Stent Kosten Effektivitäts Trial (BASKET)
-
Kaiser C, Brunner-La Rocca HP, Buser PT, et al. Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basal Stent Kosten Effektivitäts Trial (BASKET). Lancet 2005; 366: 921-929.
-
(2005)
Lancet
, vol.366
, pp. 921-929
-
-
Kaiser, C.1
Brunner-La Rocca, H.P.2
Buser, P.T.3
-
26
-
-
33750494332
-
New York State Angioplasty Registry. Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) from the New York State Angioplasty Registry
-
Feldman DN, Gade CL, Slotwiner AJ, et al; New York State Angioplasty Registry. Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) from the New York State Angioplasty Registry. Am J Cardiol 2006; 98: 1334-1339.
-
(2006)
Am J Cardiol
, vol.98
, pp. 1334-1339
-
-
Feldman, D.N.1
Gade, C.L.2
Slotwiner, A.J.3
-
27
-
-
13844275557
-
Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis
-
Nallamothu BK, Bates ER, Herrin J, et al. Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation 2005; 111: 761-767.
-
(2005)
Circulation
, vol.111
, pp. 761-767
-
-
Nallamothu, B.K.1
Bates, E.R.2
Herrin, J.3
-
28
-
-
33846582933
-
GRACE investigators. Intervention in acute coronary syndromes: Do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE)
-
Fox KA, Anderson FA Jr, Dabbous OH, et al; GRACE investigators. Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE). Heart 2007; 93: 177-182.
-
(2007)
Heart
, vol.93
, pp. 177-182
-
-
Fox, K.A.1
Anderson Jr, F.A.2
Dabbous, O.H.3
-
29
-
-
34548009153
-
Cardiologists' use of percutaneous coronary interventions for stable coronary disease
-
Lin GA, Dudley A, Redberg RF. Cardiologists' use of percutaneous coronary interventions for stable coronary disease. Arch Intern Med 2007; 167: 1604-1609.
-
(2007)
Arch Intern Med
, vol.167
, pp. 1604-1609
-
-
Lin, G.A.1
Dudley, A.2
Redberg, R.F.3
-
30
-
-
33847064642
-
In unstable angina or non-ST-segment acute coronary syndromes, should patients with multivessel coronary disease undergo multivessel or culprit-only stenting?
-
Shishehbor MH, Lauer MS, Singh IM, et al. In unstable angina or non-ST-segment acute coronary syndromes, should patients with multivessel coronary disease undergo multivessel or culprit-only stenting? J Am Coll Cardiol 2007; 49: 849-854.
-
(2007)
J Am Coll Cardiol
, vol.49
, pp. 849-854
-
-
Shishehbor, M.H.1
Lauer, M.S.2
Singh, I.M.3
-
31
-
-
14244251065
-
Contemporary management of acute coronary syndromes: Does the practice match the evidence? The Global Registry of Acute Coronary Events (GRACE)
-
Carruthers KF, Dabbous OH, Flather MD, et al. Contemporary management of acute coronary syndromes: does the practice match the evidence? The Global Registry of Acute Coronary Events (GRACE). Heart 2005; 91: 290-298.
-
(2005)
Heart
, vol.91
, pp. 290-298
-
-
Carruthers, K.F.1
Dabbous, O.H.2
Flather, M.D.3
-
32
-
-
51349129884
-
Center for Devices and Radiological Health
-
4 Jan, accessed Sep 2007
-
United States Food and Drug Administration; Center for Devices and Radiological Health. Update to FDA statement on coronary drug-eluting stents. 2007; 4 Jan. http://www.fda.gov/cdrh/news/010407.html (accessed Sep 2007).
-
(2007)
Update to FDA statement on coronary drug-eluting stents
-
-
-
33
-
-
34548693252
-
Drug-eluting stent update 2007. Part III. Technique and unapproved/unsettled indications (left main, bifurcations, chronic total occlusions, small vessels and long lesions, saphenous vein grafts, acute myocardial infarctions, and multivessel disease)
-
Colombo A, Chieffo A. Drug-eluting stent update 2007. Part III. Technique and unapproved/unsettled indications (left main, bifurcations, chronic total occlusions, small vessels and long lesions, saphenous vein grafts, acute myocardial infarctions, and multivessel disease). Circulation 2007; 116: 1424-1432.
-
(2007)
Circulation
, vol.116
, pp. 1424-1432
-
-
Colombo, A.1
Chieffo, A.2
-
34
-
-
34248329889
-
Outcomes and complications associated with off-label and untested use of drug-eluting stents
-
Beohar N, Davidson CJ, Kip KE, et al. Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA 2007; 297: 1992-2000.
-
(2007)
JAMA
, vol.297
, pp. 1992-2000
-
-
Beohar, N.1
Davidson, C.J.2
Kip, K.E.3
-
35
-
-
34248376428
-
EVENT Registry Investigators. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents
-
Win HK, Caldera AE, Maresh K, et al; EVENT Registry Investigators. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA 2007; 297: 2001-2009.
-
(2007)
JAMA
, vol.297
, pp. 2001-2009
-
-
Win, H.K.1
Caldera, A.E.2
Maresh, K.3
-
36
-
-
38549120402
-
A comparison of bare-metal and drug-eluting stents for off-label indications
-
Marroquin OC, Seizer F, Mulukutla SR, et al. A comparison of bare-metal and drug-eluting stents for off-label indications. N Engl J Med 2008; 358: 342-352.
-
(2008)
N Engl J Med
, vol.358
, pp. 342-352
-
-
Marroquin, O.C.1
Seizer, F.2
Mulukutla, S.R.3
-
37
-
-
33847762819
-
SCAAR Study Group. Long-term outcomes with drug-eluting versus bare-metal stents in Sweden
-
Lagerqvist B, James SK, Stenestrand U, et al; SCAAR Study Group. Long-term outcomes with drug-eluting versus bare-metal stents in Sweden. N Engl J Med 2007; 356: 1009-1019.
-
(2007)
N Engl J Med
, vol.356
, pp. 1009-1019
-
-
Lagerqvist, B.1
James, S.K.2
Stenestrand, U.3
-
38
-
-
51349087477
-
-
Wood S. New Swedish registry results show no overall increased deaths with DES out to four years. theheart.org 2007; 2 Sep. http://www.theheart.org/article/808471.do (accessed Jan 2008).
-
Wood S. New Swedish registry results show no overall increased deaths with DES out to four years. theheart.org 2007; 2 Sep. http://www.theheart.org/article/808471.do (accessed Jan 2008).
-
-
-
-
39
-
-
33847167065
-
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study
-
Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 2007; 369: 667-678.
-
(2007)
Lancet
, vol.369
, pp. 667-678
-
-
Daemen, J.1
Wenaweser, P.2
Tsuchida, K.3
-
40
-
-
34948904387
-
Effectiveness and safety of drug-eluting stents in Ontario
-
Tu JV, Bowen J, Chiu M, et al. Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med 2007; 357: 1393-1402.
-
(2007)
N Engl J Med
, vol.357
, pp. 1393-1402
-
-
Tu, J.V.1
Bowen, J.2
Chiu, M.3
-
41
-
-
36048973194
-
Unrestricted use of drug-eluting stents compared with bare-metal stents in routine clinical practice
-
Abbott JD, Voss MR, Nakaruma M, et al. Unrestricted use of drug-eluting stents compared with bare-metal stents in routine clinical practice. J Am Coll Cardiol 2007; 50: 2029-2036.
-
(2007)
J Am Coll Cardiol
, vol.50
, pp. 2029-2036
-
-
Abbott, J.D.1
Voss, M.R.2
Nakaruma, M.3
-
42
-
-
42449100082
-
Studies of drug-eluting stents. To each his own?
-
Mauri L, Normand ST. Studies of drug-eluting stents. To each his own? Circulation 2008; 117: 2047-2050.
-
(2008)
Circulation
, vol.117
, pp. 2047-2050
-
-
Mauri, L.1
Normand, S.T.2
-
43
-
-
45849144423
-
Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents
-
Malenka DJ, Kaplan AV, Lucas FL, et al. Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents. JAMA 2008; 299: 2868-2876.
-
(2008)
JAMA
, vol.299
, pp. 2868-2876
-
-
Malenka, D.J.1
Kaplan, A.V.2
Lucas, F.L.3
-
44
-
-
0142041382
-
Predictors of major bleeding in acute coronary syndromes: The Global Registry of Acute Coronary Events (GRACE)
-
Moscucci M, Fox KA, Cannon CP, et al. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003; 24: 1815-1823.
-
(2003)
Eur Heart J
, vol.24
, pp. 1815-1823
-
-
Moscucci, M.1
Fox, K.A.2
Cannon, C.P.3
-
45
-
-
33745058140
-
Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding
-
Khurram Z, Chou E, Minutello R, et al. Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding. J Invasive Cardiol 2006; 18: 162-164.
-
(2006)
J Invasive Cardiol
, vol.18
, pp. 162-164
-
-
Khurram, Z.1
Chou, E.2
Minutello, R.3
-
46
-
-
51349099147
-
-
Australian Institute of Health and Welfare. Australia's health 2008. Canberra: AIHW, 2008. (AIHW Cat. No. AUS 99.)
-
Australian Institute of Health and Welfare. Australia's health 2008. Canberra: AIHW, 2008. (AIHW Cat. No. AUS 99.)
-
-
-
-
47
-
-
51349110309
-
-
Davies J, Senes S. Coronary angioplasty in Australia 1999. Canberra: Australian Institute of Health and Welfare; National Heart Foundation of Australia, 2002. (AIHW Cat. No. CVD 19; Cardiovascular Disease Series No. 19.)
-
Davies J, Senes S. Coronary angioplasty in Australia 1999. Canberra: Australian Institute of Health and Welfare; National Heart Foundation of Australia, 2002. (AIHW Cat. No. CVD 19; Cardiovascular Disease Series No. 19.)
-
-
-
-
48
-
-
34848924471
-
Current management of acute coronary syndromes in Australia: Observations from the acute coronary syndromes prospective audit
-
Chew DP, Amerena J, Coverdale S, et al. Current management of acute coronary syndromes in Australia: observations from the acute coronary syndromes prospective audit. Intern Med J 2007; 37: 741-748.
-
(2007)
Intern Med J
, vol.37
, pp. 741-748
-
-
Chew, D.P.1
Amerena, J.2
Coverdale, S.3
-
49
-
-
33749592770
-
Use of drug-eluting stents in Victorian public hospitals
-
Yan BP, Ajani AE, Duffy SJ, et al. Use of drug-eluting stents in Victorian public hospitals. Med J Aust 2006; 185: 363-367.
-
(2006)
Med J Aust
, vol.185
, pp. 363-367
-
-
Yan, B.P.1
Ajani, A.E.2
Duffy, S.J.3
-
50
-
-
0034988582
-
Why Australia needs a Cardiac Procedures Database
-
Tonkin AM. Why Australia needs a Cardiac Procedures Database. Heart Lung Circ 2001; 10(1 Suppl): S22-S25.
-
(2001)
Heart Lung Circ
, vol.10
, Issue.1 SUPPL.
-
-
Tonkin, A.M.1
|